Adverse events reported by study participants
| Adverse event | SLE (N=50) | Controls (N=50) | Total (N=100) |
|---|---|---|---|
| Erythema and pain at injection site | 3 (6%) | 2 (4%) | 5 (5%) |
| Rash | 1 (2%) | 0 (0%) | 1 (1%) |
| Nausea | 1 (2%) | 0 (0%) | 1 (1%) |
| Headache | 1 (2%) | 1 (2%) | 2 (2%) |
| Irregular menses | 1 (2%) | 1 (2%) | 2 (2%) |
| Upper respiratory tract infection | 1 (2%) | 1 (2%) | 2 (2%) |
SLE, systemic lupus erythematosus.